U.K. Set to Pay £500 Million For GSK-Sanofi COVID-19 Drug

GALWAY, IRELAND--July 14, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The U.K. government is close to inking a £500 million ($624 million) deal with GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) and Sanofi (NASDAQ:SNY) (Paris, France) to supply the country with up to 60 million doses of their coronavirus vaccine. Within this article: Details proposed vaccine deal, testing timeline, related vaccine news, Sanofi plant investment in France